home
sitemap
print
recommend

2009 Portfolio News


News from the portfolios of HBM BioVentures and HBM BioCapital

30.6.2009 Sloning BioTechnology and Henkel to cooperate in enzyme development
22.6.2009 Brahms - Cezanne and Lumiphore announces partnership for diagnostic tests
16.6.2009 Vivacta raises $4.5 million to commercialise piezofilm technology
16.6.2009 MiCardia announces first U.S. implant
29.5.2009 Devax receives IDE approval to commence bifurcation stent trial
26.5.2009 mtm laboratories and MetaSystems agree on partnership to develop Automated
CINtec Cytology Imaging System
15.5.2009 Brahms - for the first time, a new Biomarker test enables detection of Alzheimer's
dementia in blood
13.5.2009 Diagnostics company BRAHMS presents positive results for 2008
7.5.2009 Merck KGaA, global partner of Newron, initiates second phase III trial of
safinamide in advanced Parkinson's disease
6.5.2009
 Anthera's varespladib meets primary endpoint in phase 2 FRANCIS trial for the
treatment of acute coronary syndrome
4.5.2009
 Lux reports first oral drug for uveitis which reduces  both inflammation and
recurrence rate in potientially blinding eye disease
4.5.2009
 Ophthotech's positive results for their Novel Therapy for Wet AMD
26.3.2009
 Lux Biosciences reports positive results from LUMINATE Phase 3 program of
LX211 (LUVENIQ) in Uveitis
24.3.2009
 ESBATech ESBA105 demonstrates efficacy in the back of the eye to inhabit
neovascularization
24.3.2009
 Anthera's IMPACTS trial demonstrates favorable interim results in preventing
sickle cell complication
23.3.2009
 Nereus Pharmaceuticals initiates randomized phase 2 clinical trial in non-small
cell lung cancer
20.4.2009
 Mpex's new CBO Mark Wiggins joins from Biogen Idec 
17.2.2009
 MiCardia announces worlds' first dynamic heart valve repair on a beating heart
3.2.2009

Newron announces improved motor function in phase III Parkinson's trial of
Safinamade